FDA to Study Patient Perceptions of Drug Ads' Effectiveness Claims

The FDA will examine how pharmaceutical manufacturers’ effectiveness claims in direct-to-consumer prescription drug advertising affect consumer beliefs about medication quality. In a two-part study, OPDP will survey patients with diabetes using nine different mock print ads with varying levels of efficacy information. Researchers will then test respondents to gauge their memory, perception and understanding of the drug risks and benefits.